Both ABCC6 (Aranyi et al., 2013) and ABCC7/CFTR (Bhattacharya et al., 2022; Kovacova et al., 2024) have also been shown by others to harbor mutations that impair function and lead to disease, suggesting they may serve as cancer‐specific vulnerabilities. This evidence concerns the gene ABCC6 and cancer.